• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

UHG’s Optum Acquires Home Health Business LHC Group for $5.4B

Share:

April 4, 2022

What You Should Know:

– UnitedHealth Group subsidiary Optum has agreed to acquire LHC Group, a national patient-focused provider of high-quality in-home health care services for $5.4 billion ($170 per share).

– The acquisition will further strengthen their shared ability to advance value-based care, especially in the comfort of a patient’s own home.

Extend Value-Based Care into Patients’ Homes

The combination of LHC Group with Optum Health, which works with over 100 health plans, unites two organizations dedicated to providing compassionate and comprehensive care to patients and their families. LHC Group’s history of high-quality home and community-based care matched with Optum’s extensive value-based care experience and resources will accelerate the combined companies’ ability to deliver integrated care, improving outcomes and patient experiences.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

LHC Group’s 30,000 employees, including frontline care providers and administrative and support personnel, provide more than 12 million annual in-home patient-focused interventions and is widely recognized as one of the highest-quality providers of in-home care, with quality scores consistently running more than one-third higher than industry norms. The LHC Group leadership team will continue forward as part of Optum Health.

Financial Details

The agreement calls for the acquisition of LHC Group’s common stock for $170 per share in cash and is expected to close in the second half of 2022 subject to LHC Group shareholder approvals, regulatory approvals, and other customary closing conditions. Co-founders Keith and Ginger Myers will personally invest $10 million in UnitedHealth Group stock following the close of the combination. The acquisition is expected to be neutral to UnitedHealth Group’s outlook for adjusted net earnings per share in 2022, modestly accretive in 2023, and advancing strongly in subsequent years.

“LHC Group’s sophisticated care coordination capabilities and its warm, human touch is so important for home care, and will greatly enhance the reach of Optum’s value-based capabilities along the full continuum of care, including primary care, home and community care, virtual care, behavioral health and ambulatory surgery,” said Dr. Wyatt Decker, CEO, Optum Health. “We greatly admire how the people of LHC Group have created a culture that enables them to be a trusted health care partner to patients and their families when they need it the most, and we look forward to working with and learning from them.”

Source: Hitconsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug CandidateOragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
  • Therapix Biosciences Provides Update on Planned Merger with Destiny Biosciences Global Corp.Therapix Biosciences Provides Update on Planned Merger with Destiny Biosciences Global Corp.
  • Immuron Receives FDA Approval for Travelan IND ApplicationImmuron Receives FDA Approval for Travelan IND Application
  • NTT DATA Collaborates with Google Cloud On Next-Gen Healthcare SolutionsNTT DATA Collaborates with Google Cloud On Next-Gen Healthcare Solutions
  • Matrix Medical Network Announces the Acquisition of BiocernaMatrix Medical Network Announces the Acquisition of Biocerna
  • Digital’s Potential in Clinical Trials, Medical AdherenceDigital’s Potential in Clinical Trials, Medical Adherence
  • Health Content Verification is the No. 1 Ethical Decision Challenging Tech Platforms in the Covid EraHealth Content Verification is the No. 1 Ethical Decision Challenging Tech Platforms in the Covid Era
  • Beyond AI: Healthcare entering an exciting, new phaseBeyond AI: Healthcare entering an exciting, new phase

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications